Skip to main content
Equibles

Decheng Capital LLC

Position in NUVB — Nuvation Bio Inc.

CIK 2010850 MENLO PARK, CA
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$147,421,213
+$36,076,670 QoQ
Shares Held
25,954,439
0.0% QoQ
Ownership
7.39%
of shares outstanding
% of Portfolio
20.15%
of 13F equity value
Holder Rank
#3
of 242 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Decheng Capital LLC holds $731,749,065 across 14 Biotechnology names. NUVB ranks #2 (20.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 6,371,669 $452,707,082
2 NUVB
Nuvation Bio Inc.
This page 		25,954,439 $147,421,213
3 AARD
Aardvark Therapeutics, Inc.
 3,917,299 $22,563,642
4 ACRS
Aclaris Therapeutics, Inc.
 4,041,736 $21,380,783
5 UPB
Upstream Bio, Inc.
 2,724,868 $18,856,086
6 RCUS
Arcus Biosciences, Inc.
 464,779 $14,329,136
7 EQ
Equillium, Inc.
 4,447,308 $14,231,385
8 RVMD
Revolution Medicines, Inc.
 52,667 $9,863,475

All Filings in NUVB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $147,421,213 25,954,439
2026-03-31 $111,344,543 25,954,439
2025-12-31 $232,551,773 25,954,439
2025-09-30 $96,031,424 25,954,439
2025-06-30 $50,611,156 25,954,439
2025-03-31 $45,679,812 25,954,439
2024-12-31 $69,038,807 25,954,439
2024-09-30 $59,435,665 25,954,439
2024-06-30 $20,294,697 6,950,239